Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Brain Research Center mikt op landelijk netwerk
aug 2019 | Dementie, Multipele Sclerose